A Worldwide Epidemic: The Problem and Challenges of Preterm Birth in Low- and Middle-Income Countries

Marcela C. Smid; Elizabeth M. Stringer; Jeffrey S. A. Stringer

doi:10.1055/s-0035-1571199

American Journal of Perinatology, Table of Contents

Am J Perinatol 2016; 33(03): 276-289
DOI: 10.1055/s-0035-1571199

Prematurity Special Issue

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Worldwide Epidemic: The Problem and Challenges of Preterm Birth in Low- and Middle-Income Countries

Marcela C. Smid

¹Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

,

Elizabeth M. Stringer

¹Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

,

Jeffrey S. A. Stringer

²Division of Global Women's Health, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

› Author Affiliations

Abstract

Preterm birth (PTB) is the most common cause of neonatal death worldwide and the second leading cause of under-5 mortality. Low- and middle-income countries (LMICs) bear a disproportionate burden of this disease. An estimated 1 million preterm infants die in the neonatal period each year and many of those who survive face lifelong disability. In this review, we explore the global burden of PTB through an examination of risk factors and predisposing clinical conditions found in LMICs. We then discuss current interventions available to prevent PTB and/or mitigate its clinical sequelae. A major finding of this review is that although the majority of the global PTB disease burden is shouldered by LMICs, very little of the research evidence for its prevention and treatment derives from these settings. Primary research and implementation studies that involve LMIC populations are urgently needed.

Keywords

global health - preterm birth - prematurity - low- and middle-income countries

Full Text

References

References
1 World Health Organization. Born Too Soon: The Global Action Report on Preterm Birth. 2012
2 Beck S, Wojdyla D, Say L , et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88 (1) 31-38
3 Lawn JE, Gravett MG, Nunes TM, Rubens CE, Stanton C ; GAPPS Review Group. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth 2010; 10 (Suppl. 01) S1
4 Blencowe H, Cousens S, Oestergaard MZ , et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379 (9832) 2162-2172
5 World Health Organization. WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 1977; 56 (3) 247-253
6 Steer P. The epidemiology of preterm labour. BJOG 2005; 112 (Suppl. 01) 1-3
7 Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371 (9606) 75-84
8 McClure EM, Wright LL, Goldenberg RL , et al; NICHD FIRST BREATH Study Group. The global network: a prospective study of stillbirths in developing countries. Am J Obstet Gynecol 2007; 197 (3) 247.e1-247.e5
9 Cousens S, Blencowe H, Stanton C , et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet 2011; 377 (9774) 1319-1330
10 Geerts L, Poggenpoel E, Theron G. A comparison of pregnancy dating methods commonly used in South Africa: a prospective study. S Afr Med J 2013; 103 (8) 552-556
11 Bengtson AWD, Musonda P, Pettifor A , et al. Multiple overimputation to address missing data and measurement error in gestational age: application to duration of HIV treatment before delivery and pregnancy outcomes. Epidemiology 2015; . In press
12 WHO, UNICEF Low Birthweight: Country, Regional and Global Estimates: New York, 2004
13 Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367 (9524) 1747-1757
14 Lee AC, Katz J, Blencowe H , et al; CHERG SGA-Preterm Birth Working Group. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health 2013; 1 (1) e26-e36
15 Villar J, Cheikh Ismail L, Victora CG , et al; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 2014; 384 (9946) 857-868
16 Rosenberg RE, Ahmed AS, Ahmed S , et al. Determining gestational age in a low-resource setting: validity of last menstrual period. J Health Popul Nutr 2009; 27 (3) 332-338
17 Villar J, Papageorghiou AT, Knight HE , et al. The preterm birth syndrome: a prototype phenotypic classification. Am J Obstet Gynecol 2012; 206 (2) 119-123
18 Barros FC, Papageorghiou AT, Victora CG , et al; International Fetal and Newborn Growth Consortium for the 21st Century. The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention. JAMA Pediatr 2015; 169 (3) 220-229
19 Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 2003; 97 (1) 30-35
20 Kulmala T, Vaahtera M, Ndekha M , et al. The importance of preterm births for peri- and neonatal mortality in rural Malawi. Paediatr Perinat Epidemiol 2000; 14 (3) 219-226
21 Vogel JP, Lee AC, Souza JP. Maternal morbidity and preterm birth in 22 low- and middle-income countries: a secondary analysis of the WHO Global Survey dataset. BMC Pregnancy Childbirth 2014; 14: 56
22 van den Broek NR, Jean-Baptiste R, Neilson JP. Factors associated with preterm, early preterm and late preterm birth in Malawi. PLoS ONE 2014; 9 (3) e90128
23 Feresu SA, Harlow SD, Woelk GB. Risk factors for low birthweight in Zimbabwean women: a secondary data analysis. PLoS ONE 2015; 10 (6) e0129705
24 Fitri LE, Jahja NE, Huwae IR, Nara MB, Berens-Riha N. Congenital malaria in newborns selected for low birth-weight, anemia, and other possible symptoms in Maumere, Indonesia. Korean J Parasitol 2014; 52 (6) 639-644
25 Singh J, Soni D, Mishra D, Singh HP, Bijesh S. Placental and neonatal outcome in maternal malaria. Indian Pediatr 2014; 51 (4) 285-288
26 Stanisic DI, Moore KA, Baiwog F , et al. Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New Guinea. Trans R Soc Trop Med Hyg 2015; 109 (5) 313-324
27 Steer P. The epidemiology of preterm labor—a global perspective. J Perinat Med 2005; 33 (4) 273-276
28 Qin J, Yang T, Xiao S, Tan H, Feng T, Fu H. Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis. PLoS ONE 2014; 9 (7) e102203
29 World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards Universal Access. Progress Report 2011. Geneva: WHO; 2011. Available at: whqlibdocwhoint/publications/2011/9789241502986_engpdf . Accessed January 26, 2014
30 Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ 2013; 91 (3) 217-226
31 Asuquo B, Vellore AD, Walters G, Manney S, Mignini L, Kunst H. A case–control study of the risk of adverse perinatal outcomes due to tuberculosis during pregnancy. J Obstet Gynaecol 2012; 32 (7) 635-638
32 Figueroa-Damián R, Arredondo-García JL. Neonatal outcome of children born to women with tuberculosis. Arch Med Res 2001; 32 (1) 66-69
33 Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet 1994; 44 (2) 119-124
34 Lin HC, Lin HC, Chen SF. Increased risk of low birthweight and small for gestational age infants among women with tuberculosis. BJOG 2010; 117 (5) 585-590
35 Klufio CA, Amoa AB, Delamare O, Hombhanje M, Kariwiga G, Igo J. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic. P N G Med J 1995; 38 (3) 163-171
36 Demba E, Morison L, van der Loeff MS , et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infect Dis 2005; 5: 12
37 Kharsany AB, Hoosen AA, Moodley J. Bacterial vaginosis and lower genital tract infections in women attending out-patient clinics at a tertiary institution serving a developing community. J Obstet Gynaecol 1997; 17 (2) 171-175
38 Purwar M, Ughade S, Bhagat B, Agarwal V, Kulkarni H. Bacterial vaginosis in early pregnancy and adverse pregnancy outcome. J Obstet Gynaecol Res 2001; 27 (4) 175-181
39 Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003; 189 (1) 139-147
40 Mayaud P, Uledi E, Cornelissen J , et al. Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect 1998; 74 (Suppl. 01) S139-S146
41 Gray RH, Wabwire-Mangen F, Kigozi G , et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185 (5) 1209-1217
42 Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol 1993; 169 (1) 175-178
43 Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013; 1: CD000262
44 Sharma R, Maimanuku LR, Morse Z, Pack AR. Preterm low birth weights associated with periodontal disease in the Fiji Islands. Int Dent J 2007; 57 (4) 257-260
45 Baskaradoss JK, Geevarghese A, Kutty VR. Maternal periodontal status and preterm delivery: a hospital based case–control study. J Periodontal Res 2011; 46 (5) 542-549
46 Mumghamba EG, Manji KP. Maternal oral health status and preterm low birth weight at Muhimbili National Hospital, Tanzania: a case-control study. BMC Oral Health 2007; 7: 8
47 Lohsoonthorn V, Kungsadalpipob K, Chanchareonsook P , et al. Is maternal periodontal disease a risk factor for preterm delivery?. Am J Epidemiol 2009; 169 (6) 731-739
48 Horton AL, Boggess KA. Periodontal disease and preterm birth. Obstet Gynecol Clin North Am 2012; 39 (1) 17-23 , vii
49 Horton AL, Boggess KA, Moss KL, Jared HL, Beck J, Offenbacher S. Periodontal disease early in pregnancy is associated with maternal systemic inflammation among African American women. J Periodontol 2008; 79 (7) 1127-1132
50 Jeffcoat M, Parry S, Sammel M, Clothier B, Catlin A, Macones G. Periodontal infection and preterm birth: successful periodontal therapy reduces the risk of preterm birth. BJOG 2011; 118 (2) 250-256
51 Michalowicz BS, Hodges JS, DiAngelis AJ , et al; OPT Study. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 2006; 355 (18) 1885-1894
52 Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic. 2013 . Available at: http://www.unaids.org/en/resources/campaigns/globalreport2013/globalreport [accessed December 6, 2014]
53 Finucane MM, Stevens GA, Cowan MJ , et al; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011; 377 (9765) 557-567
54 Aebi-Popp K, Lapaire O, Glass TR , et al; Swiss Mother And Child HIV Cohort Study. Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003–2008. J Perinat Med 2010; 38 (4) 353-358
55 Turner AN, Tabbah S, Mwapasa V , et al. Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study. J Acquir Immune Defic Syndr 2013; 64 (4) 392-399
56 Lopez M, Figueras F, Hernandez S , et al. Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS 2012; 26 (1) 37-43
57 Bansil P, Jamieson DJ, Posner SF, Kourtis AP. Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART). J Womens Health (Larchmt) 2007; 16 (2) 159-162
58 Habib NA, Daltveit AK, Bergsjø P, Shao J, Oneko O, Lie RT. Maternal HIV status and pregnancy outcomes in northeastern Tanzania: a registry-based study. BJOG 2008; 115 (5) 616-624
59 Stratton P, Tuomala RE, Abboud R , et al. Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20 (2) 179-186
60 Slyker JA, Patterson J, Ambler G , et al. Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants. BMC Pregnancy Childbirth 2014; 14: 7
61 Salihu HM, Mogos MF, August EM , et al. HIV infection and its impact on fetal outcomes among women of advanced maternal age: a propensity score weighted matching approach. AIDS Res Hum Retroviruses 2013; 29 (3) 581-587
62 Pattinson RC, Hulsbergen MH, Van Hoorick L. The effect of maternal HIV infection on maternal conditions and perinatal deaths in southwest Tshwane. Facts Views Vis Obgyn 2010; 2 (4) 227-231
63 Olagbuji BN, Ezeanochie MC, Ande AB, Oboro VO. Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria. Arch Gynecol Obstet 2010; 281 (6) 991-994
64 Ellis J, Williams H, Graves W, Lindsay MK. Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol 2002; 186 (5) 903-906
65 Coley JL, Msamanga GI, Fawzi MC , et al. The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania. BJOG 2001; 108 (11) 1125-1133
66 Traisathit P, Mary JY, Le Coeur S , et al. Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV. J Obstet Gynaecol Res 2009; 35 (2) 225-233
67 Musana JW, Ojwang SB, Khisa W, Kiarie JN. Pregnancy outcomes in mothers with advanced human immunodeficiency virus disease. East Afr Med J 2009; 86 (10) 480-485
68 Abrams ET, Milner Jr DA, Kwiek J , et al. Risk factors and mechanisms of preterm delivery in Malawi. Am J Reprod Immunol 2004; 52 (2) 174-183
69 Chen JY, Ribaudo HJ, Souda S , et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 2012; 206 (11) 1695-1705
70 Azria E, Moutafoff C, Schmitz T , et al. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen. Antivir Ther 2009; 14 (3) 423-432
71 Boer K, Nellen JF, Patel D , et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 2007; 114 (2) 148-155
72 Ezechi OC, Gab-Okafor CV, Oladele DA , et al. Pregnancy, obstetric and neonatal outcomes in HIV positive Nigerian women. Afr J Reprod Health 2013; 17 (3) 160-168
73 Lopez M, Figueras F, Hernandez S , et al. Association of HIV infection with spontaneous and iatrogenic preterm delivery: effect of HAART. AIDS 2012; 26 (1) 37-43
74 Haeri S, Shauer M, Dale M , et al. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. Am J Obstet Gynecol 2009; 201 (3) 315.e1-315.e5
75 Parekh N, Ribaudo H, Souda S , et al. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana. Int J Gynaecol Obstet 2011; 115 (1) 20-25
76 Kourtis AP, Bansil P, McPheeters M, Meikle SF, Posner SF, Jamieson DJ. Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003. AIDS 2006; 20 (14) 1823-1831
77 Rudin C, Spaenhauer A, Keiser O , et al; Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV). Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data. HIV Med 2011; 12 (4) 228-235
78 Patil S, Bhosale R, Sambarey P , et al. Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India. AIDS Care 2011; 23 (12) 1562-1569
79 Onah HE, Obi SN, Agbata TA, Oguanuo TC. Pregnancy outcome in HIV-positive women in Enugu, Nigeria. J Obstet Gynaecol 2007; 27 (3) 271-274
80 Ndirangu J, Newell ML, Bland RM, Thorne C. Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod 2012; 27 (6) 1846-1856
81 da Costa TP, Leal MC, Mota JC , et al. Comparison of pregnancy characteristics and outcomes between HIV-infected and HIV-non-infected women in Brazil. AIDS Care 2013; 25 (6) 686-690
82 HIV/AIDS JUNPo. Financial Resources Required to Achieve Universal Access to HIV Prevention, Treatment, Care and Support. Geneva: World Health Organization; 2007
83 Lorenzi P, Spicher VM, Laubereau B , et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS 1998; 12 (18) F241-F247
84 van der Merwe K, Hoffman R, Black V, Chersich M, Coovadia A, Rees H. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc 2011; 14: 42
85 Martin F, Taylor GP. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study. J Infect Dis 2007; 196 (4) 558-561
86 Darak S, Darak T, Kulkarni S , et al. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India. AIDS Patient Care STDS 2013; 27 (3) 163-170
87 European Collaborative Study; Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14 (18) 2913-2920
88 Sibiude J, Warszawski J, Tubiana R , et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?. Clin Infect Dis 2012; 54 (9) 1348-1360
89 Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007; 21 (8) 1019-1026
90 Machado ES, Hofer CB, Costa TT , et al. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception. Sex Transm Infect 2009; 85 (2) 82-87
91 Thorne C, Patel D, Newell ML. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18 (17) 2337-2339
92 Kourtis AP, Fowler MG. Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers. J Infect Dis 2011; 204 (4) 493-494
93 Short C-ES, Taylor GP. Antiretroviral therapy and preterm birth in HIV-infected women. Expert Rev Anti Infect Ther 2014; 12 (3) 293-306
94 Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007; 21 (5) 607-615
95 Powis KM, Kitch D, Ogwu A , et al. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis 2011; 204 (4) 506-514
96 Koss CA, Natureeba P, Plenty A , et al. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr 2014; 67 (2) 128-135
97 Schutte MF, Treffers PE, Koppe JG, Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour. Br J Obstet Gynaecol 1980; 87 (2) 127-131
98 Papiernik E, Cohen H, Richard A, de Oca MM, Feingold J. Ethnic difference in duration of pregnancy. Ann Hum Biol 1986; 13 (3) 259-265
99 Patel RR, Steer P, Doyle P, Little MP, Elliott P. Does gestation vary by ethnic group? A London-based study of over 122,000 pregnancies with spontaneous onset of labour. Int J Epidemiol 2004; 33 (1) 107-113
100 Olowe SA, Akinkugbe A. Amniotic fluid lecithin/sphingomyelin ratio: comparison between an African and North American community. Pediatrics 1978; 62 (1) 38-41
101 Papiernik E, Alexander GR, Paneth N. Racial differences in pregnancy duration and its implications for perinatal care. Med Hypotheses 1990; 33 (3) 181-186
102 Torloni MR, Betrán AP, Daher S , et al. Maternal BMI and preterm birth: a systematic review of the literature with meta-analysis. J Matern Fetal Neonatal Med 2009; 22 (11) 957-970
103 Kanadys WM, Leszczyńska-Gorzelak B, Jedrych M, Oleszczuk J. Maternal pre-pregnancy obesity and the risk of preterm birth: a systematic overview of cohort studies with meta-analysis [in Polish]. Ginekol Pol 2012; 83 (4) 270-279
104 Parker MG, Ouyang F, Pearson C , et al. Prepregnancy body mass index and risk of preterm birth: association heterogeneity by preterm subgroups. BMC Pregnancy Childbirth 2014; 14: 153
105 McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutr 2009; 12 (4) 444-454
106 Stevens GA, Finucane MM, De-Regil LM , et al; Nutrition Impact Model Study Group (Anaemia). Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health 2013; 1 (1) e16-e25
107 Scholl TO, Hediger ML. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr 1994; 59 (2, Suppl): 492S-500S , discussion 500S–501S
108 Scholl TO, Hediger ML, Fischer RL, Shearer JW. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr 1992; 55 (5) 985-988
109 Klebanoff MA, Shiono PH, Selby JV, Trachtenberg AI, Graubard BI. Anemia and spontaneous preterm birth. Am J Obstet Gynecol 1991; 164 (1, Pt 1): 59-63
110 Osendarp SJ, West CE, Black RE ; Maternal Zinc Supplementation Study Group. The need for maternal zinc supplementation in developing countries: an unresolved issue. J Nutr 2003; 133 (3) 817S-827S
111 Ngoc NT, Merialdi M, Abdel-Aleem H , et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ 2006; 84 (9) 699-705
112 Ratzon R, Sheiner E, Shoham-Vardi I. The role of prenatal care in recurrent preterm birth. Eur J Obstet Gynecol Reprod Biol 2011; 154 (1) 40-44
113 Cecatti JG, Correa-Silva EP, Milanez H, Morais SS, Souza JP. The associations between inter-pregnancy interval and maternal and neonatal outcomes in Brazil. Matern Child Health J 2008; 12 (2) 275-281
114 Conde-Agudelo A, Belizán JM. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study. BMJ 2000; 321 (7271) 1255-1259
115 Shah NR, Bracken MB. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol 2000; 182 (2) 465-472
116 Glynn T, Seffrin JR, Brawley OW, Grey N, Ross H. The globalization of tobacco use: 21 challenges for the 21st century. CA Cancer J Clin 2010; 60 (1) 50-61
117 Amos A, Greaves L, Nichter M, Bloch M. Women and tobacco: a call for including gender in tobacco control research, policy and practice. Tob Control 2012; 21 (2) 236-243
118 Boy E, Bruce N, Delgado H. Birth weight and exposure to kitchen wood smoke during pregnancy in rural Guatemala. Environ Health Perspect 2002; 110 (1) 109-114
119 Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000; 78 (9) 1078-1092
120 Pope DP, Mishra V, Thompson L , et al. Risk of low birth weight and stillbirth associated with indoor air pollution from solid fuel use in developing countries. Epidemiol Rev 2010; 32: 70-81
121 Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry 2010; 67 (10) 1012-1024
122 Patel V, Rahman A, Jacob KS, Hughes M. Effect of maternal mental health on infant growth in low income countries: new evidence from South Asia. BMJ 2004; 328 (7443) 820-823
123 Rahman A, Iqbal Z, Harrington R. Life events, social support and depression in childbirth: perspectives from a rural community in the developing world. Psychol Med 2003; 33 (7) 1161-1167
124 Stringer EM, Meltzer-Brody S, Kasaro M , et al. Depression, pregnancy, and HIV: the case to strengthen mental health services for pregnant and post-partum women in sub-Saharan Africa. Lancet Psychiatry 2014; 1 (2) 159-162
125 Meltzer-Brody S, Stringer EM. Global maternal, newborn, and child health. N Engl J Med 2014; 370 (11) 1072
126 Spong CY, Mercer BM, D'alton M, Kilpatrick S, Blackwell S, Saade G. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011; 118 (2, Pt 1): 323-333
127 Tita AT, Landon MB, Spong CY , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009; 360 (2) 111-120
128 De Luca R, Boulvain M, Irion O, Berner M, Pfister RE. Incidence of early neonatal mortality and morbidity after late-preterm and term cesarean delivery. Pediatrics 2009; 123 (6) e1064-e1071
129 Vogel JP, Souza JP, Gülmezoglu AM. Patterns and outcomes of induction of labour in Africa and Asia: a secondary analysis of the WHO Global Survey on Maternal and Neonatal Health. PLoS ONE 2013; 8 (6) e65612
130 Villar J, Valladares E, Wojdyla D , et al; WHO 2005 global survey on maternal and perinatal health research group. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006; 367 (9525) 1819-1829
131 Lumbiganon P, Laopaiboon M, Gülmezoglu AM , et al; World Health Organization Global Survey on Maternal and Perinatal Health Research Group. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08. Lancet 2010; 375 (9713) 490-499
132 Victora CG, Rubens CE ; GAPPS Review Group. Global report on preterm birth and stillbirth (4 of 7): delivery of interventions. BMC Pregnancy Childbirth 2010; 10 (Suppl. 01) S4
133 Owusu-Edusei Jr K, Gift TL, Ballard RC. Cost–effectiveness of a dual non-treponemal/treponemal syphilis point-of-care test to prevent adverse pregnancy outcomes in sub-Saharan Africa. Sex Transm Dis 2011; 38 (11) 997-1003
134 Rydzak CE, Goldie SJ. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis 2008; 35 (9) 775-784
135 Sangkomkamhang US, Lumbiganon P, Prasertcharoensuk W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 2015; 2: CD006178
136 Luntamo M, Kulmala T, Mbewe B, Cheung YB, Maleta K, Ashorn P. Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. Am J Trop Med Hyg 2010; 83 (6) 1212-1220
137 Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW ; Nutrition Impact Model Study Group (anaemia). Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 2013; 346: f3443
138 Imdad A, Bhutta ZA. Nutritional management of the low birth weight/preterm infant in community settings: a perspective from the developing world. J Pediatr 2013; 162 (3, Suppl): S107-S114
139 Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev 2013; 3: CD006896
140 Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2015; 7: CD004736
141 van Eijk AM, De Cock KM, Ayisi JG , et al. Pregnancy interval and delivery outcome among HIV-seropositive and HIV-seronegative women in Kisumu, Kenya. Trop Med Int Health 2004; 9 (1) 15-24
142 Barros FC, Bhutta ZA, Batra M, Hansen TN, Victora CG, Rubens CE ; GAPPS Review Group. Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions. BMC Pregnancy Childbirth 2010; 10 (Suppl. 01) S3
143 Barros FC, Victora CG, Barros AJ , et al. The challenge of reducing neonatal mortality in middle-income countries: findings from three Brazilian birth cohorts in 1982, 1993, and 2004. Lancet 2005; 365 (9462) 847-854
144 Iams JD, Romero R, Culhane JF, Goldenberg RL. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008; 371 (9607) 164-175
145 Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009; (3) CD001055
146 Meis PJ, Klebanoff M, Thom E , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348 (24) 2379-2385
147 Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012; 120 (4) 964-973
148 Jabeen S, Akhtar M, Fatima N. Role of progesterone for the prevention of preterm labor. Pak J Med Sci 2012; (Jan-Mar)
149 Khan FK, Intsar A, Khurshid S. Prevention of recurrent preterm delivery by 17 alpha hydroxyl progesterone caproate. Biomedica 2013; 29: 92
150 da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188 (2) 419-424
151 Hassan SS, Romero R, Vidyadhari D , et al; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38 (1) 18-31
152 Romero R, Nicolaides K, Conde-Agudelo A , et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206 (2) 124.e1-124.e19
153 Cetingoz E, Cam C, Sakallı M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011; 283 (3) 423-429
154 O'Brien JM, Adair CD, Lewis DF , et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30 (5) 687-696
155 Many in VOICE trial didn't use provided prevention products. AIDS Policy Law 2015; 30 (4) 3
156 Friedman AM, Schwartz N, Ludmir J, Parry S, Bastek JA, Sehdev HM. Can transabdominal ultrasound identify women at high risk for short cervical length?. Acta Obstet Gynecol Scand 2013; 92 (6) 637-641
157 Friedman AM, Srinivas SK, Parry S, Elovitz MA, Wang E, Schwartz N. Can transabdominal ultrasound be used as a screening test for short cervical length?. Am J Obstet Gynecol 2013; 208 (3) 190.e1-190.e7
158 Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev 2013; 5: CD007873
159 Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 2012; 4: CD008991
160 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No.142: Cerclage for the management of cervical insufficiency. Obstet Gynecol 2014; 123 (2, Pt 1): 372-379
161 Odibo AO, Elkousy M, Ural SH, Macones GA. Prevention of preterm birth by cervical cerclage compared with expectant management: a systematic review. Obstet Gynecol Surv 2003; 58 (2) 130-136
162 Owen J, Hankins G, Iams JD , et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009; 201 (4) 375.e1-375.e8
163 Rafael TJ, Berghella V, Alfirevic Z. Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy. Cochrane Database Syst Rev 2014; 9: CD009166
164 MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100 (6) 516-523
165 Egwuatu VE. Complications of cervical cerclage in Igbo women. J Natl Med Assoc 1986; 78 (3) 245-246
166 World Health Organization. WHO Recommendations on Interventions to Improve Preterm Birth Outcomes. 2015
167 Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50 (4) 515-525
168 Block MF, Kling OR, Crosby WM. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstet Gynecol 1977; 50 (2) 186-190
169 Amorim MM, Santos LC, Faúndes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999; 180 (5) 1283-1288
170 Doran TA, Swyer P, MacMurray B , et al. Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1980; 136 (3) 313-320
171 Fekih M, Chaieb A, Sboui H, Denguezli W, Hidar S, Khairi H. Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study [in French]. Tunis Med 2002; 80 (5) 260-265
172 Gamsu HR, Mullinger BM, Donnai P, Dash CH. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial. Br J Obstet Gynaecol 1989; 96 (4) 401-410
173 Garite TJ, Rumney PJ, Briggs GG , et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992; 166 (2) 646-651
174 Lewis DF, Brody K, Edwards MS, Brouillette RM, Burlison S, London SN. Preterm premature ruptured membranes: a randomized trial of steroids after treatment with antibiotics. Obstet Gynecol 1996; 88 (5) 801-805
175 Morales WJ, Angel JL, O'Brien WF, Knuppel RA. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstet Gynecol 1989; 73 (5, Pt 1): 721-726
176 Nelson LH, Meis PJ, Hatjis CG, Ernest JM, Dillard R, Schey HM. Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstet Gynecol 1985; 66 (1) 55-58
177 Qublan HS, Malkawi HY, Hiasat MS , et al. The effect of antenatal corticosteroid therapy on pregnancies complicated by premature rupture of membranes. Clin Exp Obstet Gynecol 2001; 28 (3) 183-186
178 Taeusch Jr HW, Frigoletto F, Kitzmiller J , et al. Risk of respiratory distress syndrome after prenatal dexamethasone treatment. Pediatrics 1979; 63 (1) 64-72
179 Pattinson RC, Makin JD, Funk M , et al; Dexiprom Study Group. The use of dexamethasone in women with preterm premature rupture of membranes—a multicentre, double-blind, placebo-controlled, randomised trial. S Afr Med J 1999; 89 (8) 865-870
180 Eronen M, Kari A, Pesonen E, Hallman M. The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus. A randomized double-blind study. Am J Dis Child 1993; 147 (2) 187-192
181 Teramo K, Hallman M, Raivio KO. Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant. Pediatr Res 1980; 14 (4, Pt 1): 326-329
182 Silver RK, Vyskocil C, Solomon SL, Ragin A, Neerhof MG, Farrell EE. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation. Obstet Gynecol 1996; 87 (5, Pt 1): 683-691
183 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; (3) CD004454
184 Committee on Obstetric Practice. ACOG committee opinion. Antenatal corticosteroid therapy for fetal maturation American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 78 (1) 95-97
185 Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn JE. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol 2010; 39 (Suppl. 01) i122-i133
186 Vogel JP, Souza JP, Gülmezoglu AM , et al; WHO Multi-Country Survey on Maternal and Newborn Health Research Network. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet 2014; 384 (9957) 1869-1877
187 Althabe F, Belizán JM, McClure EM , et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 2015; 385 (9968) 629-639
188 van Stralen G, van der Bos J, Lopriore E , et al. No short-term benefits of antenatal corticosteroid treatment in severely preterm growth restricted fetuses: a case-control study. Early Hum Dev 2009; 85 (4) 253-257
189 Torrance HL, Derks JB, Scherjon SA, Wijnberger LD, Visser GH. Is antenatal steroid treatment effective in preterm IUGR fetuses?. Acta Obstet Gynecol Scand 2009; 88 (10) 1068-1073
190 Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA. Rates of and factors associated with recurrence of preterm delivery. JAMA 2000; 283 (12) 1591-1596
191 Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003; (2) CD001058
192 Cousens S, Blencowe H, Gravett M, Lawn JE. Antibiotics for pre-term pre-labour rupture of membranes: prevention of neonatal deaths due to complications of pre-term birth and infection. Int J Epidemiol 2010; 39 (Suppl. 01) i134-i143
193 Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev 2013; 12: CD000246
194 Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998; 17 (6) 499-503
195 Mulholland EK, Ogunlesi OO, Adegbola RA , et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J 1999; 18 (10, Suppl): S35-S41
196 Muhe L, Tilahun M, Lulseged S , et al. Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediatr Infect Dis J 1999; 18 (10, Suppl): S56-S61
197 Bomela HN, Ballot DE, Cooper PA. Is prophylaxis of early-onset group B streptococcal disease appropriate for South Africa?. S Afr Med J 2001; 91 (10) 858-860
198 Tan KW, Tay L, Lin R, Daniel M, Bhavani S, Lim SH. Group B Streptococcal septicaemia/meningitis in neonates in a Singapore teaching hospital. Aust N Z J Obstet Gynaecol 1998; 38 (4) 418-423
199 Kuruvilla KA, Pillai S, Jesudason M, Jana AK. Bacterial profile of sepsis in a neonatal unit in south India. Indian Pediatr 1998; 35 (9) 851-858
200 McNamara HC, Crowther CA, Brown J. Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour. Cochrane Database Syst Rev 2015; 12: CD011200
201 Flenady V, Wojcieszek AM, Papatsonis DN , et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev 2014; 6: CD002255
202 Vogel JP, Nardin JM, Dowswell T, West HM, Oladapo OT. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev 2014; 7: CD006169
203 Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2014; 2: CD004352
204 Flenady V, Wojcieszek AM, Papatsonis DN , et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev 2014; 6: CD002255
205 Lawn JE, Cousens SN, Darmstadt GL , et al; Lancet Neonatal Survival Series Steering Team. 1 year after The Lancet Neonatal Survival Series—was the call for action heard?. Lancet 2006; 367 (9521) 1541-1547
206 Lawn JE, Mwansa-Kambafwile J, Horta BL, Barros FC, Cousens S. ‘Kangaroo mother care’ to prevent neonatal deaths due to preterm birth complications. Int J Epidemiol 2010; 39 (Suppl. 01) i144-i154
207 Conde-Agudelo A, Díaz-Rossello JL. Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev 2014; 4: CD002771
208 van den Heuvel M, Blencowe H, Mittermayer K , et al. Introduction of bubble CPAP in a teaching hospital in Malawi. Ann Trop Paediatr 2011; 31 (1) 59-65
209 Murguia-Peniche T, Kirsten GF. Meeting the challenge of providing neonatal nutritional care to very or extremely low birth weight infants in low-resource settings. World Rev Nutr Diet 2014; 110: 278-296
210 World Health Organization, UNICEF. Global Strategy for Infant and Young Child Feeding. Geneva, Switzerland: World Health Organization; 2003